STAHL NEIL

Company

Date

Role

Action

Shares

Amount

Of holding

REGN Regeneron Pharmaceuticals

8 Aug 2024

EVP Research and Development

Sold on a plan

5,197

$5.64M

9.2%

REGN Regeneron Pharmaceuticals

7 Feb 2024

EVP Research and Development

Sold at will

8,037

$7.64M

13.4%

REGN Regeneron Pharmaceuticals

22 Aug 2023

EVP Research and Development

Sold at will

11,665

$9.81M

18.0%

REGN Regeneron Pharmaceuticals

5 Aug 2022

EVP Research and Development

Sold, plan not stated

23,782

$14.57M

31.1%

REGN Regeneron Pharmaceuticals

17 May 2021

EVP Research and Development

Sold, plan not stated

17,521

$9.10M

41.9%

REGN Regeneron Pharmaceuticals

11 May 2020

EVP Research and Development

Sold, plan not stated

5,305

$3.02M

31.8%

REGN Regeneron Pharmaceuticals

14 Apr 2020

EVP Research and Development

Sold, plan not stated

5,497

$2.86M

32.6%

REGN Regeneron Pharmaceuticals

27 Feb 2020

EVP Research and Development

Sold, plan not stated

10,349

$4.68M

47.6%

REGN Regeneron Pharmaceuticals

13 Feb 2020

EVP Research and Development

Sold, plan not stated

10,278

$4.12M

47.5%

REGN Regeneron Pharmaceuticals

26 Nov 2019

EVP Research and Development

Sold, plan not stated

4,006

$1.46M

15.1%

REGN Regeneron Pharmaceuticals

8 Nov 2019

EVP Research and Development

Sold, plan not stated

7,364

$2.49M

24.7%

REGN Regeneron Pharmaceuticals

14 May 2019

EVP Research and Development

Sold, plan not stated

9,853

$3.01M

30.5%

REGN Regeneron Pharmaceuticals

24 May 2018

EVP Research and Development

Sold, plan not stated

11,407

$3.37M

26.3%

REGN Regeneron Pharmaceuticals

22 Jun 2017

EVP Research and Development

Sold, plan not stated

8,306

$4.42M

25.8%

REGN Regeneron Pharmaceuticals

15 Jun 2017

EVP Research and Development

Sold, plan not stated

8,567

$4.01M

26.3%

REGN Regeneron Pharmaceuticals

2 Jun 2017

EVP Research and Development

Sold, plan not stated

2,812

$1.35M

10.5%

REGN Regeneron Pharmaceuticals

9 Nov 2015

EVP Research and Development

Sold, plan not stated

22,101

$12.38M

50.1%

REGN Regeneron Pharmaceuticals

6 Nov 2015

EVP Research and Development

Sold, plan not stated

20,000

$11.26M

31.2%

REGN Regeneron Pharmaceuticals

24 Nov 2014

SVP Research and Development S

Sold, plan not stated

2,200

$901.52K

40.2%

REGN Regeneron Pharmaceuticals

21 Nov 2014

SVP Research and Development S

Sold, plan not stated

3,107

$1.29M

36.2%

REGN Regeneron Pharmaceuticals

11 Aug 2014

SVP Research and Development S

Sold, plan not stated

11,646

$3.96M

46.3%

REGN Regeneron Pharmaceuticals

8 Aug 2014

SVP Research and Development S

Sold, plan not stated

2,100

$715.34K

7.7%

REGN Regeneron Pharmaceuticals

7 Aug 2014

SVP Research and Development S

Sold, plan not stated

741

$252.30K

2.6%

REGN Regeneron Pharmaceuticals

13 Feb 2014

SVP Research and Development S

Sold, plan not stated

22,612

$7.21M

48.1%

REGN Regeneron Pharmaceuticals

13 May 2013

SVP Research and Development S

Sold, plan not stated

23,038

$6.38M

32.0%

REGN Regeneron Pharmaceuticals

30 Nov 2012

SVP Res and Devel Sciences

Sold, plan not stated

17,182

$3.11M

29.1%

REGN Regeneron Pharmaceuticals

21 Nov 2012

SVP Res and Devel Sciences

Sold, plan not stated

24,357

$4.25M

29.2%

REGN Regeneron Pharmaceuticals

29 Aug 2012

SVP Research and Development S

Sold, plan not stated

16,884

$2.46M

22.2%

REGN Regeneron Pharmaceuticals

19 Jun 2012

SVP Res & Dev Sciences

Sold, plan not stated

38,911

$4.51M

39.7%

REGN Regeneron Pharmaceuticals

15 Feb 2012

SVP Research and Development S

Sold, plan not stated

21,082

$2.27M

26.3%

REGN Regeneron Pharmaceuticals

14 Feb 2012

SVP Research and Development S

Sold, plan not stated

31,202

$3.44M

28.0%

REGN Regeneron Pharmaceuticals

7 Sep 2011

SVP Research and Development S

Sold, plan not stated

33,760

$2.35M

40.1%

REGN Regeneron Pharmaceuticals

5 Apr 2011

SVP Res and Dev Sciences

Sold, plan not stated

34,115

$1.57M

40.4%

REGN Regeneron Pharmaceuticals

30 Mar 2011

SVP Res and Dev Sciences

Sold, plan not stated

7,692

$346.14K

13.3%

REGN Regeneron Pharmaceuticals

27 Jul 2009

SVP Res and Dev Sciences

Sold, plan not stated

26,886

$558.23K

98.7%

REGN Regeneron Pharmaceuticals

24 Jul 2009

SVP Res and Dev Sciences

Sold, plan not stated

10,537

$210.74K

96.8%

REGN Regeneron Pharmaceuticals

30 Sep 2008

SVP, Research & Devel Sciences

Sold, plan not stated

10,317

$223.12K

96.7%

REGN Regeneron Pharmaceuticals

23 Apr 2007

SVP, Research & Devel Sciences

Sold, plan not stated

10,988

$281.39K

71.9%

REGN Regeneron Pharmaceuticals

1 Nov 2006

SVP, Therap & Clin Prog Dev

Sold, plan not stated

5,760

$115.20K

59.7%

REGN Regeneron Pharmaceuticals

31 Oct 2006

SVP, Therap & Clin Prog Dev

Sold, plan not stated

41,689

$834.64K

81.2%